Expert Interview
A Second Look: Reviewing the LUNA 3 phase 3 study from Sanofi on their BTK inhibitor, Rilzabrutinib for immune thrombocytopenia
Ticker(s): SNYInstitution: Cancer Care Centers of South Texas
Hematologist/Oncologist at Cancer Care Centers of South Texas and Clinical Associate Professor in Medicine at the University of Texas Health Science Center at San Antonio.
Currently treats 10-12 patients with Follicular lymphoma and/or refractory B-cell non-Hodgkin lymphoma
Specializing in the management of all adult solid tumors, lymphomas and leukemias.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
